abstract |
The invention belongs to the medicine chemical field, and more specifically relates to a novel quinazoline compound having antineoplastic activity in a formula I and a preparation method. The compound 1 has effective protein tyrosine kinases irreversible inhibition effect and/or has good internal pharmacokinetics behavior, and is an effective protein tyrosine kinases irreversible inhibitor. |